Chinese drug discovery services and incubation company headquartered in the Zhangjiang high technology park in Shanghai, founded in 2008 and listed in Hong Kong. Provides structure based drug discovery services covering protein production, X-ray crystallography and cryo-electron microscopy structure determination, biophysical and functional assays and hit to lead and lead optimisation chemistry, particularly for difficult targets such as membrane proteins, and runs an equity for service incubation business investing in early stage biotechnology companies alongside contract development and manufacturing capacity.
コメントはありません。
評価とコメントを残す